Lv51
1560 积分 2023-01-06 加入
Gastric Cancer
2小时前
已完结
Frontiers in Uro-Oncology
4天前
求助中
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials
7天前
已完结
Successful second conversion surgery after trastuzumab deruxtecan for recurrent HER2-positive gastric cancer
7天前
已完结
Twenty-four-month Progression-free Survival in HER2-amplified Advanced Gastric Cancer with Brain Metastases after Trastuzumab Deruxtecan Treatment: A Case Report and Literature Review
7天前
已完结
Antibody–drug conjugates in gastric cancer: clinical advances and resistance mechanisms
7天前
已完结
Trastuzumab deruxtecan in the treatment of HER2-positive gastric cancer: a comprehensive review
7天前
已完结
DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance
7天前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
7天前
已完结
Risk Factors for Contrast Media Extravasation in Intravenous Contrast-Enhanced Computed Tomography: An Observational Cohort Study
17天前
已完结
皖公网安备34019202002308
